Therapeutic solutions for rare diseases
Over 2/3 of LFB’s medicinal products are indicated for rare diseases, making it a major player in this field. LFB’s medicinal products help hospital-based healthcare professionals treat patients with diseases that are sometimes very rare and for which there are few therapeutic options.
What is a rare disease ?
The term “rare disease” refers to a condition affecting fewer than 1 in 2,000 people* in Europe, and about 3 million in France, suffer from a rare disease in 2016*.
In the world we estimate that 263 to 446 million people is affected by a rare disease, which equates to 3.5–5.9% of the worldwide population**. There are 7,000 to 8,000 rare diseases worldwide, 80% of which are of genetic origin. In Europe 30 million* people have a rare disease. Haemophilia, Primary Immunodeficiency (PID), immune-mediated neuropathies, deficiencies of certain proteins, are all rare diseases that profoundly affect people’s lives.